FoundationOne®CDx je potvrđen sveobuhvatan genski test za sve solidne tumore.
This website is a global information resource. It is intended for healthcare professionals only outside of the United States of America (US) who are interested in information on Foundation Medicine®. This site is not intended to provide medical advice and/or treatment guidance. If you are a US healthcare professional click here.
This site is produced by Roche as a partner of Roche Foundation Medicine.
Saznajte kako FoundationOne®CDx može pomoći u kreiranju Vašeg individualnog plana liječenja.
PD-L1 IHC test može biti naručen kao dodatna usluga uz FoundationOne CDx.
*Base substitutions, insertions or deletions, copy number alterations and gene rearrangements.
EGFR, epidermal growth factor receptor. FDA, US Food and Drug Administration. FISH, fluorescence in situ hybridisation. IHC, immunohistochemistry. MSI, microsatellite instability. NCCN, National Comprehensive Cancer Network. NGS, next generation sequencing. NSCLC, non-small cell lung cancer. PD-L1, programmed death-ligand 1.
TKI tyrosine kinase inhibitor. TMB, tumour mutational burden.